Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Agonism and Antagonism: Quantification

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Combined Effects of Drugs: Antagonism

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

Pharmacodynamic Models: Linear Concentration–Effect Model

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

AMPHIBIAN PARASITES EXHIBIT IDIOSYNCRATIC RELATIONSHIPS WITH SPATIOTEMPORAL ENVIRONMENTAL AND HOST-COMMUNITY VARIATION.

The Journal of parasitology·2025

Same author

Botanical oleander extract and oleandrin have superior effects on innate immune functions pertaining to dermal allergic reactions in canine cells when compared to oclacitinib.

American journal of veterinary research·2024

Same author

PBI-05204, a supercritical CO<sub>2</sub> extract of Nerium oleander, suppresses glioblastoma stem cells by inhibiting GRP78 and inducing programmed necroptotic cell death.

Neoplasia (New York, N.Y.)·2024

Same author

Preliminary investigation of the safe dose of oleandrin when administered orally to Beagles.

Journal of the American Veterinary Medical Association·2024

Same author

Oleander attenuates hepatic inflammation in a TLR4-independent manner and by favorable modulation of hepatocellular global metabolome that supports cytoprotection.

Journal of ethnopharmacology·2024

Same author

Differential Activities of the Botanical Extract PBI-05204 and Oleandrin on Innate Immune Functions under Viral Challenge Versus Inflammatory Culture Conditions.

Molecules (Basel, Switzerland)·2023

Search research articles

Related Experiment Video

Updated: Jul 12, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Quantifying synergism/antagonism using nonlinear mixed-effects modeling: a simulation study.

John C Boik¹, Robert A Newman, Robert J Boik

¹Graduate School of Biomedical Sciences, University of Texas, Houston, TX, U.S.A. jcboik@stanford.edu

Statistics in Medicine

|September 5, 2007

Summary

The new MixLow method accurately assesses cancer drug interactions using the Loewe additivity index and nonlinear mixed-effects models. It offers more precise parameter estimation and reliable confidence intervals compared to existing methods.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Related Experiment Videos

Last Updated: Jul 12, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Area of Science:

Pharmacology
Biostatistics
Computational Biology

Background:

Cancer drugs are often given as combinations, necessitating methods to evaluate drug interactions.
Existing methods for assessing drug synergy or antagonism rely on various additive models.
Accurate quantification of drug interactions is crucial for optimizing cancer therapy.

Purpose of the Study:

To introduce and validate the MixLow method for quantifying drug interactions in cancer research.
To compare the performance of the MixLow method against the established Median-Effect method.
To provide a robust statistical framework for analyzing fixed-ratio drug combinations.

Main Methods:

Utilized the Loewe additivity index as the basis for interaction assessment.
Employed nonlinear mixed-effects models for estimating concentration-response curve parameters.
Developed a procedure for calculating confidence intervals for the interaction index, termed the MixLow method.

Main Results:

The MixLow method demonstrated more precise parameter estimation than the Median-Effect method in simulations.
Confidence interval coverage was acceptable for MixLow but poor for the Median-Effect method.
Analysis of a vincristine and topotecan mixture validated the MixLow method's applicability.

Conclusions:

The MixLow method offers a statistically sound approach for analyzing drug interactions in fixed-ratio combinations.
It provides improved precision and reliability in quantifying synergistic and antagonistic effects.
This method is suitable for studies with sigmoidal dose-response patterns and replicates.